Welcome to BioMarket Group!

Analytical Tool - Lymphoma

Additional Information

Published Date Mar 25, 2014
Pages No
License Prices No
PDF Fact Sheet No
Format PDF & Desktop App plus Online Access to Updates (One Year)
Publisher BioSeeker Group

Availability: In stock

$4,650.00

Quick Overview

A unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development.
Request free sample pages from Analytical Tool - Lymphoma

"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding the right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
and Lymphoma Drug Pipeline Update 2014*
.


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in lymphoma R&D
  • Information on key industry related lymphoma projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs


This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of lymphoma therapeutics
  • Identifying emerging lymphoma products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of lymphoma drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.



License Prices:

Request free sample pages from Analytical Tool - Lymphoma

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Protein Kinase Inhibitors in Oncology
Adopt knowledge from this analysis to drive strategic planning decisions in PKI drug development in oncology. Learn More


Analytical Tool - Breast Cancer
The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development. Learn More

Other selected research from the 'R&D' category:


Analytical Tool - Apoptosis in Oncology
In this Analytical Tool, BioSeeker Group brings light and understanding of the whole industrial endeavor in apoptosis as cancer therapeutic mechanism. Learn More


Analytical Tool - Angiogenesis in Oncology
The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

Other selected research from the 'Oncology' category:


Renal Cancer Drug Pipeline Update
BioSeeker Group have identified 243 companies plus partners who are today developing 270 drugs targeting renal cancer in development. across 233 different targets. In addition, there are 3 suspended drugs and another 95 drugs where development has been ceased. Learn More


Analytical Tool - Peptides in Oncology
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer peptide R&D and business development. Learn More